SOBR Safe (NASDAQ:SOBR) Issues Quarterly Earnings Results, Beats Expectations By $218.92 EPS

SOBR Safe (NASDAQ:SOBR) posted its earnings results on Friday. The company reported ($1.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($220.00) by $218.92, Zacks reports. The firm had revenue of $0.03 million for the quarter, compared to analyst estimates of $0.53 million. SOBR Safe had a negative net margin of 2,166.28% and a negative return on equity of 172.71%.

SOBR Safe Stock Down 5.0%

Shares of SOBR stock opened at $0.55 on Friday. SOBR Safe has a 52 week low of $0.35 and a 52 week high of $3.97. The firm has a 50 day moving average of $0.76 and a 200-day moving average of $0.86. The company has a market cap of $1.55 million, a price-to-earnings ratio of -0.10 and a beta of 1.23.

Institutional Trading of SOBR Safe

A hedge fund recently bought a new stake in SOBR Safe stock. XTX Topco Ltd acquired a new stake in shares of SOBR Safe, Inc. (NASDAQ:SOBR) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,695 shares of the company’s stock, valued at approximately $34,000. XTX Topco Ltd owned approximately 1.04% of SOBR Safe as of its most recent SEC filing. Institutional investors own 7.93% of the company’s stock.

Analyst Ratings Changes

SOBR has been the subject of several analyst reports. Wall Street Zen raised SOBR Safe to a “sell” rating in a research report on Saturday, August 1st. Weiss Ratings reiterated a “sell (e+)” rating on shares of SOBR Safe in a report on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

SOBR Safe Company Profile

SOBR Safe, Inc (NASDAQ: SOBR) is a technology company specializing in the development and commercialization of cognitive impairment monitoring solutions. The company’s flagship offerings consist of handheld breath alcohol screening devices and integrated cognitive assessment tools designed to detect impairment in real time. SOBR Safe’s product line pairs portable breathalyzers with proprietary software that captures, records and analyzes impairment data to help organizations maintain safety and compliance standards.

Founded in 2020 and headquartered in Vancouver, Canada, SOBR Safe has focused on research and development of non-invasive impairment detection technology.